Showing 2 results for Homocysteine.
Nagmeh Alsabah Alavizadeh , Keyvan Hejazi, Tohid Mabhout Moghadam ,
Volume 12, Issue 4 (7-2018)
Abstract
ABSTRACT
Background and objectives: Visfatin is a newly characterized adipokine, which is highly expressed in visceral adipose tissue. The aim of this study was to evaluate effects of aerobic exercise training on visfatin, homocystein, C-reactive protein and lipid profile in sedentary men.
Methods: In this quasi-experimental study, 27 sedentary men were selected by convenience sampling method. The subjects were divided into a control group (n=13) and an aerobic training group (n=14). The subjects in the experimental group performed 60 minutes of aerobic exercise at 75-85% of maximum heart rate, three sessions per week for eight weeks. Data were analyzed in SPSS 16.0 (SPSS Inc., Chicago, IL, USA) using paired and independent sample t-test for comparison of means within and between groups, respectively. A P-value of less than 0.05 was considered statistically significant.
Results: The eight-week aerobic exercise training significantly reduced body weight (P=0.02), body mass index (P=0.01) and low-density lipoprotein-cholesterol (P=0.03) levels. It also caused a significant increase in the high-density-lipoprotein-cholesterol (P=0.00) and a significant decrease in visfatin levels (P=0.005). Serum homocysteine and C-reactive protein levels decreased by the end of the training program, but these changes were not statistically significant (P>0.05).
Conclusion: The eight-week aerobic exercise program could effectively improve lipid profile and visfatin levels. Therefore, this type of exercise could be recommended for prevention of cardiovascular disease and improvement of its risk factors.
Keywords: Aerobic, C-reactive protein, Exercise, Homocysteine.
Saif Karim, Mahdi Zahedi, Nahid Poursharifi, Mehdi Khorami, Mohsen Tatar,
Volume 19, Issue 2 (3-2025)
Abstract
Objective: The purpose of this study was to investigate the impact of smoking on blood homocysteine, folic acid, and vitamin B12 levels in patients with cardiovascular diseases (CVD). Methods: We collected 90 participants with cardiovascular complications who were divided into two groups: Smokers (n=46) and non-smokers (n=44) groups. The serum levels of homocysteine, folic acid, and vitamin B12 were determined by the ELISA. Additionally, the systolic, diastolic blood pressure, and BMI were taken from patients. Results: Our results illustrated that the serum level of folic acid was significantly decreased in smoker patients (22.41±5.95) compared with the non-smokers group (28.05±4.13, p=0.000). In contrast, the serum level of homocysteine (p=0.958) and vitamin B12 (p=0.578) was not altered significantly between both groups. Our data also showed a negative correlation between folic acid and systolic blood pressure. No relationship was observed between folic acid and vitamin B12 and homocysteine in the smoking group. Conclusion: Our study showed that the levels of folic acid significantly decreased in CVD patients with smokers compared with non-smokers. A significant negative relationship was observed between folic acid and systolic blood pressure.
